Quarter*              

(millions, except per share data)

  First

  Second

 Third

 Fourth

   Year*

1999

Revenues

$ 6,580

$ 6,516 

$6,746

$7,534 

$27,376 

Costs and expenses:

Cost of sales

1,262

1,179 

1,567

1,456 

5,464 

Selling, informational and administrative expenses

2,641

2,660 

2,566

2,943 

10,810 

Research and development expenses

929

949 

1,041

1,117 

4,036 

Other (income)/deductions--net

     38

     64 

    32

   (13)

    121 

Income from continuing operations before provision for taxes on income and minority interests

1,710

1,664 

1,540

2,031 

6,945 

Provision for taxes on income

495

482 

431

560 

1,968 

Minority interests

      1

      1 

     1

     2 

      5 

Income from continuing operations

1,214

1,181 

1,108

1,469 

4,972 

Discontinued operations--net of tax

      -

    (20)

     -

     - 

    (20)

Net income

$ 1,214
=======

$ 1,161 
======= 

$1,108
======

$1,469 
====== 

$ 4,952 
======= 

Earnings per common share--basic

Income from continuing operations

$   .20 =======

$   .19 
======= 

$  .18
======

$  .24 
====== 

$   .81 
======= 

Net income

$   .20 =======

$   .19 
======= 

$  .18
======

$  .24 
====== 

$   .81 
======= 

Earnings per common share--diluted

Income from continuing operations

$   .19

$   .19 

$  .18

$  .23 

$   .79 

Discontinued operations--net of tax

      -

  (.01)

     -

     - 

   (.01)

Net income

$   .19
=======

$   .18 
======= 

$  .18
======

$  .23 
====== 

$   .78 
======= 

Weighted average shares--basic

6,123
=======

6,124 
======= 

6,122
======

6,131 
====== 

6,126 
======= 

Weighted average shares--diluted

6,360 =======

6,338 
======= 

6,322
======

6,310 
====== 

6,317 
======= 

Cash dividends per common share

$.07 1/3
=========

$.07 1/3 
========= 

$  .08
======

$  .08 
====== 

$.30 2/3 
======= 

              Quarter*              

(millions, except per share data)

  First

  Second

 Third

 Fourth

   Year*

Income from continuing operations before provision for taxes on income and minority interests

$1,710 

$1,697

$1,850

$2,031

$7,288

Net income

$1,214 

$1,190

$1,313

$1,469

$5,186

Earnings per common share--diluted

$  .19 

$  .19

$  .21

$  .23

$  .82

The 1999 results above exclude the following:

Significant item:

Charge to write off Trovan inventories ($205 million after tax) (1)

$  310 

Merger-related costs:

Costs associated with the acquisition of Agouron Pharmaceuticals, Inc. ($29 million after tax) (2)

    33 

Total significant items and merger-related costs, pre-tax

343 

Income taxes

  (109)

Total significant items and merger-related costs, after-tax

$  234 
======